Skip to main content

Table 2 Pathological evaluation after surgery in the two groups

From: Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis

 

nCRT (n = 60, %)

nCT (n = 60, %)

P

R0

52 (86.7)

43 (71.7)

0.026

R1

1 (1.6)

9 (15.0)

 

Non surgery

7 (11.7)

8 (13.3)

 
 

nCRT (n = 53, %)

nCT (n = 52, %)

P

pCR rate

9 (17.0)

1 (1.9)

0.030

Lymphovascular invasion

5 (9.4)

12 (23.1)

0.058

Nerval invasion

3 (5.7)

12 (23.1)

0.011

Lymph node metastasis

20 (37.7)

30 (57.7)

0.041

Node positive rate

4.4 (55/1245)

23.4 (433/1853)

 < 0.001